Kilian Huber
Nuffield Department of Medicine

Biography
Professor Huber received his doctorate in Medicinal and Pharmaceutical ÀË»¨Ö±²¥ from the Ludwig-Maximilians-Universität (LMU) in Munich working on the design and synthesis of natural product-inspired kinase inhibitors.
After postdoctoral studies at the University of Oxford and at the Research Centre for Molecular Medicine (CeMM), Vienna, he joined the Structural Genomics Consortium (SGC)and Target Discovery Institute (TDI) in Oxford in 2015 as Principal Investigator. In 2019, he assumed the role of Senior Chemical Biology Group Leader at the Centre for Medicines Discovery (CMD). He has received numerous awards and prizes, including the GSK Discovery Fast Track Challenge in 2014, the 2015 Young Investigator Award from the German Pharmaceutical Society (DPhG-Stiftung/Horst-Böhme-Stiftung), and a ThermoFisher TMT Research Award in 2017.
Kilian's primary research interests focus on exploring cellular signalling networks by developing specific chemical probes and chemical biology approaches to identify new therapeutic targets for treating human diseases.
RSC affiliations
Editorial board, RSC Chemical Biology